MARKET PULSE- Campbell Soup, Best Buy, Horizon Pharma, Daktronics

Tue Nov 19, 2013 9:59am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For more market insights, including options activity, click on ; for the Day Ahead newsletter; for the Morning News Call newsletter, U.S. stocks opened flat at the open on Tuesday after the Dow and S&P 500 hit record highs the previous session, with a few earnings reports expected to dominate trading amid a lack of broad market catalysts. The Dow Jones industrial average rose 0.12 percent, while the S&P 500 lost 0.02 percent and the Nasdaq Composite dropped 0.02 percent.

** CAMPBELL SOUP CO, $39.48, down 6 pct (9:32 a.m. ET)

The world's largest soup maker cut its full-year profit forecast after a drop in demand for its soups and drinks resulted in first-quarter earnings that fell far short of analyst estimates.


The Canadian company said late on Monday that it received approval from the U.S. Food and Drug Administration to sell the generic version of Novartis Pharmaceuticals Corp's drug, Focalin XR. Commercial sale of Focalin, used to treat attention deficit hyperactivity disorder, will be launched by Intellipharmaceutical's U.S. partner Par Pharmaceutical Inc.

** SPHERIX INC, $10.88, up 45 pct (9:33 a.m. ET)   Continued...